Skip to main content
TipRanks
Go Ultimate75% OFF

Natalie Sacks Insider Profile

4 Followers

Natalie Sacks, Director at Caribou Biosciences, holds ― shares in Caribou Biosciences (Ticker: CRBU), holds 173.72K shares in Chinook Therapeutics (Ticker: KDNY), holds ― shares in Zymeworks (Ticker: ZYME).

Natalie Sacks's Trading History

KDNY
Chinook Therapeutics
Sep 14, 2018―Uninformative Buy―$7.02M
HARP
Harpoon Therapeutics
―――$1.05M
ZYME
Zymeworks
―Director――
CRBU
Caribou Biosciences
―Director――

You May Also Like

Natalie Sacks insider profile FAQ

What is the percentage of profitable transactions made by Natalie Sacks?
The percentage of profitable transactions made by Natalie Sacks is 100%.
What is the average return per transaction made by Natalie Sacks?
The average return per transaction made by Natalie Sacks is 65.90%.
What stocks does Natalie Sacks hold?
Natalie Sacks holds: CRBU, KDNY, ZYME, HARP stocks.
What was Natalie Sacks's most profitable transaction?
Natalie Sacks’s most profitable transaction was an Informative Sell of KDNY stock on September 6, 2018. The return on the trade was 84.30%.
What is Natalie Sacks's role in Caribou Biosciences?
Natalie Sacks's role in Caribou Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.